The contractile actomyosin cytoskeleton and its connection to the plasma membrane are critical for control of cell shape and migration. We identify three STRIPAK complex components, FAM40A, FAM40B and STRN3, as regulators of the actomyosin cortex. We show that FAM40A negatively regulates the MST3 and MST4 kinases, which promote the co-localization of the contractile actomyosin machinery with the Ezrin/Radixin/Moesin family proteins by phosphorylating the inhibitors of PPP1CB, PPP1R14A-D. Using computational modelling, in vitro cell migration assays and in vivo breast cancer metastasis assays we demonstrate that co-localization of contractile activity and actin-plasma membrane linkage reduces cell speed on planar surfaces, but favours migration in confined environments similar to those observed in vivo. We further show that FAM40B mutations found in human tumours uncouple it from PP2A and enable it to drive a contractile phenotype, which may underlie its role in human cancer.
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The contractile actomyosin cytoskeleton and its connection to the plasma membrane are critical for control of cell shape and migration. We identify three STRIPAK complex components, FAM40A, FAM40B and STRN3, as regulators of the actomyosin cortex. We show that FAM40A negatively regulates the MST3 and MST4 kinases, which promote the co-localization of the contractile actomyosin machinery with the Ezrin/Radixin/Moesin family proteins by phosphorylating the inhibitors of PPP1CB, PPP1R14A-D. Using computational modelling, in vitro cell migration assays and in vivo breast cancer metastasis assays we demonstrate that co-localization of contractile activity and actin-plasma membrane linkage reduces cell speed on planar surfaces, but favours migration in confined environments similar to those observed in vivo. We further show that FAM40B mutations found in human tumours uncouple it from PP2A and enable it to drive a contractile phenotype, which may underlie its role in human cancer.
Cell migration is fundamental to multicellular organism development and pathology 1, 2 . The actin cytoskeleton controls cell migration by changing cell shape: actin polymerization pushes the plasma membrane forward, whereas actomyosin contraction pulls the plasma membrane and generates hydrostatic pressure 3, 4 . Moreover, actin coupling to the surrounding matrix or neighbouring cells through cell adhesion molecules enables force transmission and cell migration [5] [6] [7] [8] . Migrating cells have different morphologies depending on the balance of these factors 9 . Fibroblasts move with elongated morphologies and apply force to surrounding matrices through integrin-mediated adhesions. Leukocytes have more rounded and rapidly changing morphologies and move through interstitial collagen independently of integrins 10, 11 , but still depend on a contractile actomyosin cytoskeleton for migration. Invasive cancer cells can use both modes of migration 10, 12 . Despite knowing many of the factors that connect the actin cytoskeleton to integrins or the plasma membrane, the molecular 'tuning' mechanism that determines whether the actin network is predominantly coupled to the plasma membrane or integrins, and which is predicted to influence the mode of cancer cell migration, and thereby metastasis, remains unclear.
Actomyosin contractility is regulated by the phosphorylation of myosin light chain (MLC2/MYL9) on Thr 18 and Ser 19 (ref. 6 ).
MLC2 can be phosphorylated by many kinases, including MLCK, MRCKα and β and ROCK1 and 2 (ref. 6) , and is dephosphorylated by protein phosphatase 1 (PP1) complexes 13, 14 . Targeting of the catalytic PPP1CB subunit to the actomyosin cytoskeleton requires PPP1R12A (MYPT1/MBS) and is negatively regulated by ROCK1/2-mediated phosphorylation of PPP1R12A (refs 6,15) . The contractile actomyosin network can transmit force to the surrounding matrix by being coupled to integrin complexes 16 . Alternatively, it can be coupled to the plasma membrane through linker proteins such as the Ezrin/Radixin/Moesin (ERM) family 17 , resulting in cell morphology changes and generation of hydrostatic pressure. ERM protein linkage to the plasma membrane is regulated by phosphorylation of Ezrin (Thr 567)/Radixin (Thr 564)/Moesin (Thr 558) (ref. 17) , which are also dephosphorylated by PP1 complexes 18 . Protein phosphatase 2 (PP2) complexes contain multiple regulatory (B, B , B and B (the last group are also known as striatins)) and scaffolding subunits 19 and can also affect cell migration and actomyosin cytoskeleton 20, 21 . The striatin regulatory subunit (known as cka in Drosophila) is required for the actomyosin-driven dorsal closure process in Drosophila and other subunits are implicated in cell morphology control 22, 23 . In mammals, core PP2A proteins such as striatins form part of the multi-subunit STRIPAK complex [24] [25] [26] [27] [28] , which also includes MST family kinases 24 . MST3, MST4 and SOK1 are involved in Golgi morphogenesis, cell polarity, ERM protein phosphorylation, and regulation of tyrosine phosphatases, and can affect cell migration [29] [30] [31] [32] [33] [34] . Here we propose that the STRIPAK complex regulates the mode of cancer cell migration by controlling the activity of MST3 and 4, which locally coordinate the phosphorylation of ERM proteins and inhibit the dephosphorylation of MLC leading to increased actinmembrane linkage.
RESULTS

FAM40A and FAM40B regulate cell contractility
To identify regulators of actin-based cell migration, we performed a screen for genes required for border cell migration and actin organization in follicle cells within the Drosophila egg chamber 35 . The results of this screen are presented in Supplementary Fig. 1 . Given that several of the genes involved in this well-studied cell migration system are also involved in cancer cell dissemination [36] [37] [38] [39] [40] [41] , we reasoned that the human homologues of the identified genes may play a role in cancer cell migration. We selected 85 human homologues of 43 Drosophila genes involved in border cell migration or follicle cell architecture for further analysis (Supplementary Table 1 ). Depletion of 32 of these genes in human A431 carcinoma cells led to altered F-actin organization ( Supplementary Fig. 1c and Table 1 ). We focused on FAM40A, FAM40B and STRN3 as they are known to form a physical complex 24, 42 . Depletion of Drosophila FAM40 and STRN (Cka/CG7392) delayed border cell migration ( Supplementary Fig. 1d ,e), which was associated with perturbed localization of pMoesin ( Supplementary  Fig. 1f ). FAM40A and STRN3 depletion in A431 cells led to increased cortical pS19-MLC, pT18pS19-MLC staining and phospho-ERM staining, frequent membrane blebs ( Fig. 1b and Supplementary Fig. 2b ). In contrast, FAM40B-depleted cells had increased cell area, prominent lamellipodia, and less intense cortical pS19-MLC, pT18S19-MLC and pERM staining (Fig. 1a-c and Supplementary Fig. 2a,b and Video 1). Multiple short interfering RNAs (siRNAs) against FAM40A and FAM40B gave consistent phenotypes ( Supplementary Fig. 2c,d ). As the total levels of pS19-MLC, pT18S19-MLC and pERM were not greatly changed in FAM40A-or FAM40B-depleted cells (Fig. 1d) , they probably regulate a pool of pMLC and pERM associated with the cell cortex.
To determine whether FAM40A and B influence cell morphology in cancer cells that have undergone epithelial-mesenchymal transition we depleted FAM40A and FAM40B in MDA-MB-231 cells, yielding similar phenotypes to the epitheliod A431 cell line (Fig. 1e-l and Supplementary Fig. 2d ). FAM40A depletion increased cortical pS19-MLC and pERM staining, and reduced cell area ( Fig. 1f and Supplementary Fig. 2e ). FAM40B depletion had the opposite effect; however, pS19-MLC was still observed in stress fibres (Fig. 1e ) and pERM in a crescent in the lamellipod (Fig. 1i) . Although prominent focal adhesions were occasionally observed in FAM40B-depleted cells (Fig. 1i) , quantitative analysis failed to reveal consistent changes in cell-ECM adhesion ( Supplementary Fig. 2f-h ) and depletion of FAM40A or FAM40B did not affect the force-mediated matrix deformation by MDA-MB-231 cells (Fig. 1j) .
FAM40A depletion promotes cortical localization of both actomyosin and ERM proteins (Fig. 1b-d ,h,i and Supplementary   Fig. 2d,e) . In contrast, when FAM40B is depleted pERM and pMLC localize in different parts of the cell. We confirmed this by measuring the spatial correlation coefficient of pS19-MLC and Ezrin-GFP. MDA-MB-231 cells have a spatial correlation coefficient of ∼0.4, and this increases to ∼0.6 when FAM40A is depleted (Fig. 1k ,l, white bars). FAM40B depletion reduced the spatial correlation coefficient to ∼0.2 in FAM40B-depleted MDA-MB-231 cells (Fig. 1k,l) . A more pronounced decrease in Ezrin-GFP/pS19-MLC co-localization was observed in A431 cells (Fig. 1k,l) . As a control, the correlation of cytosolic GFP with pS19-MLC was ∼0.1 and did not vary when FAM40A and FAM40B were depleted ( Supplementary Fig. 2i ). Structured illumination microscopy demonstrated that the spatial correlation between non-muscle MyoIIa (MYH9) and Ezrin was regulated in the same manner as the pS19-MLC/Ezrin correlation ( Supplementary Fig. 2j ). Gain-of-function analysis confirmed the relevance of coordinated MLC and ERM regulation to the contractile phenotype observed in FAM40A-depleted cells. A reduction in cell area was observed only when expression of 'activated' phosphomimetic mutants MLC-T18D, S19D (MLC-DD) and Ezrin-T567D (Ez-D) was combined (Fig. 1m) . These data indicate that coordinated regulation of pMLC and pERM is required to reduce cell area.
Interdependence of ROCK1 and 2 and FAM40A and B function
The data outlined above demonstrate that FAM40A and FAM40B are involved in the coordinated regulation of MLC and ERM proteins. As RhoA and its effectors, ROCK1 and 2, regulate both MLC and ERM protein phosphorylation 43 , we investigated the relationship between FAM40A and B and RhoA-ROCK signalling. Using a RhoA FRET (fluorescence resonance energy transfer) biosensor we observed that RhoA activity at the cell cortex was not greatly changed by modulation of FAM40A or FAM40B levels (Fig. 2a,b) . We next investigated whether there was any functional interaction between FAM40A, FAM40B and ROCK1 and 2. The contractile phenotype (reduced cell area, increased cortical pS19-MLC, and membrane blebbing) of FAM40A-depleted cells was completely reversed by ROCK1 and 2 inhibition using Y-27632 (Fig. 2c,d ). Temporal analysis revealed that the reduction in pS19-MLC levels following Y-27632 treatment proceeded with slower kinetics in FAM40A-depleted cells (Fig. 2e) , indicating that the phosphatase for pS19-MLC could be less active in FAM40A-depleted cells. Having established that ROCK function was required for the phenotype of FAM40A-depleted cells, we tried the converse experiment by increasing ROCK2 function with a conditionally activated allele (ROCK2:ER-activated by 4-OH tamoxifen; ref. 44) . ROCK2:ER-expressing cells became contracted when treated with 4-OHT; however, this was prevented by FAM40B depletion (Fig. 2f ).
MST3 and 4 act downstream of FAM40A
Having established that FAM40A and B are unlikely to be directly modulating the RhoA and ROCK1 and 2 activities, we sought other explanations for their cytoskeletal effects. FAM40A and FAM40B are part of the STRIPAK complex that contains both MST kinases and PP2A-targeting subunits. Depletion of MST3 and MST4 and the CCM3 scaffold protein in MDA-MB-231 cells reduced cortical actomyosin, increased cell area, and generated an arc of pERM in the lamellipod (Fig. 3a-d) . Similar phenotypes were observed in A431 Supplementary Fig. 9 . Staining shows F-actin (red) and pS19-MLC2 (white). All statistical tests were performed using one-way ANOVA, Sidak's multiple comparison test, * * * P < 0.001. All experiments were conducted at least 3 independent times. Scale bars, 10 µm. Fig. 3a-d) . MST4 depletion had a more modest effect than MST3 depletion ( Fig. 3a-d ). Simultaneous depletion of MST3 and MST4 using either siRNAs targeting MST3 and MST4 independently or a single siRNA that targets both (MST3 siRNA21) resulted in a more pronounced phenotype (Fig. 3a-c) , which correlated with the reduction in active phosphorylated MST3 and 4 levels (compare Fig. 3b and Fig. 3e -owing to conservation of the activation loop a single phospho-antibody recognizes both active MST3 and MST4). siRNA targeting the related kinases, MST1, MST2 and SOK1, did not affect cell morphology ( Supplementary Fig. 3e-h ).
cells (Supplementary
Although cells lacking either MST3 and 4 or CCM3 had reduced cortical pS19-MLC and a more spread morphology, they still had pS19-MLC staining on stress fibres (Fig. 3a) , and reducing MST3 and 4 levels did not affect total pS19-MLC levels, but led to a slight increase in pERM (Fig. 3b) . Moreover, pS19-MLC and Ezrin-GFP were spatially segregated following depletion of MST3 and 4 and CCM3 (Fig. 3e) . . All statistical test were performed using one-way ANOVA, Sidak's multiple comparison test, * P < 0.05, * * P < 0.01, * * * P < 0.001. All experiments were conducted at least 3 independent times. Scale bars, 10 µm. Uncropped images of blots are shown in Supplementary Fig. 9 .
Epistasis experiments to test whether integrin function is required for the cell morphology changes following FAM40A or FAM40B depletion showed that depletion of ITGB1, TLN and VCL neither prevented FAM40A depletion from promoting a more contractile phenotype, nor prevented FAM40B depletion from promoting a more spread phenotype ( Supplementary Fig. 3i ). We conclude that FAM40A and FAM40B are not controlling cell morphology through direct regulation of cell-matrix adhesions (see also Fig. 1 and Supplementary Fig. 2f-h ).
These data demonstrate that MST3 and 4 are involved in cytoskeletal regulation, either by controlling PP2A phosphatase activity, which then regulates actomyosin, or because PP2A regulates the activity of MST3 and 4, which act 'downstream' of PP2A to regulate the cytoskeleton. To distinguish these possibilities we monitored the MST3 and 4 activities in response to perturbation of PP2A function and depletion of STRIPAK components. MST3 and 4 activities were markedly increased on FAM40A depletion and in response to the PP2A inhibitor okadaic acid (Fig. 4a,b ), indicating that PP2A and FAM40A negatively regulate the activity of MST3 and 4. To further investigate the underlying mechanism and reasons for the divergent phenotype of FAM40A and FAM40B depletion, we observed through sequence comparison of FAM40A and FAM40B that the amino-and carboxy-terminal regions were divergent and subject to alternative splicing (Fig. 4c) . We reasoned that FAM40A might negatively regulate MST3/4 by recruiting PP2A catalytic subunits into a complex also containing the kinases. Further, we speculated that FAM40B1 and FAM40B2 isoforms might show differential binding to the PP2A catalytic subunits due to their divergent C termini. After confirming that both FAM40B1 and FAM40B2 were expressed in MDA-MB-231 and A431 cells (Fig. 4d) , we observed that FAM40A, FAM40B1 and FAM40B2 all interact with MST3 ( Fig. 4e ). In contrast, the different FAM40 isoforms show differential binding to PP2A catalytic subunits. Although both FAM40A and FAM40B1 co-immunoprecipitate with PPP2CA and PPP2CB, FAM40B2 does not (Fig. 4f) . None of the FAM40 proteins interacted with PPP2R1A ( Fig. 4f) . We propose that FAM40A and FAM40B1 negatively regulate MST3 and 4 by enabling the formation of a complex containing MST3 and 4 and PPP2CA and B, which dephosphorylate the activation loop of the kinases. FAM40B2 may act as a competitive inhibitor of FAM40A and FAM40B1 function. Indeed overexpression of FAM40B2, which cannot bind PP2A catalytic sub-units, induces contractility (Fig. 4g ). These data argue that FAM40A regulates cell morphology by controlling the PP2A-mediated inactivation of MST3 and 4. Consistent with this, the contractile phenotype of both FAM40A-depleted cells and okadaic acid-treated cells was not observed if MST3 and 4 were also depleted ( Fig. 4h and Supplementary Fig. 3j ).
CCM3 regulates the sub-cellular localization of MST3 and 4
The data above indicate that MST3 and 4 are linked to the localized regulation of pMLC and pERM, but do not address the spatial localization of MST3 and 4. Immunostaining revealed enrichment of active phosphorylated MST3 and 4 around the outer edge of A431 cell clusters (Fig. 5a ). CCM3 was localized at the cell periphery, but also at cell-cell contacts (Fig. 5b) . Analysis of the dynamic localization of MST3-GFP, MLC-GFP and Ezrin-GFP in response to serum stimulation, which promotes ROCK-dependent actomyosin contractility 45 , revealed a transient MST3-GFP enrichment at cell-cell junctions at around 100 s and a more long-lived increase at the edges of cell clusters ( Fig. 5c and Supplementary Video 2). MST3 and 4 activity was also increased (Fig. 5d ) and similar changes were seen in the localization of both Ezrin-GFP and MLC-GFP ( Supplementary  Fig. 4a,b) . The correlation coefficient of pS19-MLC and Ezrin and membrane blebbing were also increased by serum stimulation ( Fig. 5e and Supplementary Fig. 4c ). Disruption of actomyosin contractility using a ROCK inhibitor or CCM3 depletion prevented the MST3 translocation in response to serum stimulation ( Fig. 5c and Supplementary Video 2). This was not linked to its biochemical activity as judged by pMST3 and 4 immunoblot analysis ( Fig. 5f ) and CCM3 localization was not dependent on actomyosin function (Fig. 5g) . We conclude that CCM3 and the actomyosin network combine to recruit MST3 to the edge of A431 cell clusters and cell-cell contacts.
FAM40B, MST3 and 4 and CCM3 antagonize two-dimensional migration but are required for metastasis Actomyosin contractility and ERM proteins are known to be involved in migration; however, their role can be context dependent 11 . We used a computational model to investigate the effect of perturbing the co-localization of actomyosin contraction and actin cortex to plasma membrane attachment in different matrix geometries 45 . The contractile machinery and connection to the plasma membrane were either co-located on the same side of the cell or on opposite sides (left and right side of the velocity heat map, respectively). Three matrix geometries were considered: one corresponded to a twodimensional (2D) migration assay, the second to squeezing through a series of gaps, and the third mimicked an in vivo environment. We varied the relationship between actomyosin contractility and actin cortex to plasma membrane linkage. Co-localization of contractile function and plasma membrane-actin cortex linkage was predicted to reduce the efficiency of cell migration on 2D surfaces (Fig. 6a ). This was because blebbing at the front of the cell disrupted the formation of lamellipodia. In contrast, this organization was favourable for migration in matrix geometries that required cell squeezing through gaps (Fig. 6a, middle and right panels) . This suggested that a positive spatial correlation between actomyosin and cortex-membrane attachment, similar to FAM40A depletion, would be slightly detrimental to 2D migration but favourable for squeezing through gaps. In contrast, no correlation or an inverse correlation between these parameters favoured migration on a planar surface (Fig. 6a, left panel) . To test these predications, we performed migration assays on a rigid 2D substrate, through 8 µm pores in a 6.5-µm-thick membrane, and tested the ability of cells to extravasate in vivo.
Cells depleted of FAM40B, MST3 and 4 and CCM3 migrated faster and more persistently on 2D surfaces (Fig. 6b,c and Supplementary  Fig. 5b ) and formed stable lamellipodia (Supplementary Video 3 and Fig. 6b kymograph) . In contrast, FAM40A-depleted cells had lower cell speeds, were less persistent (Fig. 6b,c and Supplementary Video 3), and exhibited highly dynamic blebbing (Supplementary Video 4 and kymograph in Fig. 6b ). These analyses are consistent with the computational prediction that weak co-localization of actomyosin and actin cortex-membrane linkage favours 2D migration. Modelling also predicted that co-localization of actomyosin contractility and actin-membrane attachment at the cell rear is favourable for squeezing depletion. MDA-MB-231 cells were stained for F-actin (red) and pS19-MLC (green). All experiments were conducted at least 3 independent times. Scale bars, 10 µm. Uncropped images of blots are shown in Supplementary Fig. 9 . through gaps (Fig. 6a and modelling of the pore dimensions of Transwell dishes in Supplementary Fig. 5 ). FAM40B, MST3 and 4 and CCM3 depletion that disrupts the ability of cells to co-localize their actomyosin network with actin-membrane linkers (ERM proteins) reduces the ability of MDA-MB-231 cells to migrate through 8 µm pores (Fig. 6d) .
Our computational analysis showed that varying the colocalization of the contractile machinery and actin-plasma membrane connection would have opposite effects on 2D surfaces and in vivo. FAM40B, MST3 and 4 and CCM3 depletion, which reduce pMLC/Ezrin co-location, would be expected to reduce migration in vivo. We tested this hypothesis by intravenously injecting mixed populations of control and target-gene-depleted MDA-MB-231 and evaluating their ability to extravasate and enter the lung parenchyma after 48 h. When mCherry-expressing control cells were mixed with GFP-expressing control cells, an equal number of both cell types was detected after both 2 and 48 h (Fig. 6e) . However, FAM40B depletion significantly reduced the number of cells in the lung after 48 h. Similar results were achieved by targeting FAM40B, MST3 and 4 and CCM3 with additional siRNAs (Fig. 6e) . FAM40A depletion, which causes the opposite phenotype to FAM40B depletion, led to a small increase in the efficiency of lung colonization (Fig. 6e) . We further examined the role of STRIPAK complexes in metastasis by generating cells that moderately overexpressed FAM40A or MST3 and testing their The analysis includes a truly prognostic data set (g), early-stage lymph-node-negative patients (h) and aggressive basal subtype of breast cancer patients (i). The Kaplan-Meier analyses for MST4 and CCM3 were performed using the publicly available data sets http://kmplot.com/analysis/. All statistical test were performed using one-way ANOVA, Sidak's multiple comparison test, * P < 0.05, * * P < 0.01, * * * P < 0.001. All experiments were conducted at least 3 independent times. Scale bars as indicated. Statistical tests were performed using one-way ANOVA, Sidak's multiple comparison test, * * * P < 0.001. All experiments were conducted at least 3 independent times.
ability to metastasize from a primary tumour in the mammary fat pad to the inguinal lymph nodes (overexpression levels shown in Supplementary Fig. 6b ). MST3 overexpression increased the ability of MDA-MB-231 cells to metastasize (Fig. 6f ), whereas FAM40A expression had the opposite effect (Fig. 6f) .
Altered expression of STRIPAK components in cancer
Analysis of available human breast cancer data sets revealed elevated expression of MST3, MST4 and CCM3 in more aggressive breast cancer sub-types ( Supplementary Fig. 6c ), with high levels of MST4 and CCM3 expression indicating a worse distant metastasis-free survival within lymph-node-negative, grade 1 and grade 2 disease, and basal breast cancer (Fig. 6h,i) 
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. The expression of other STRIPAK components, STRN3 and STRN4, decreased in aggressive breast cancer sub-types ( Supplementary Fig. 6c ). Simultaneous depletion of all three STRNs in MDA-MB-231 cells confirmed that they are negative regulators of MST3 and 4 ( Supplementary Fig. 6d) .
Analysis of data from The Cancer Genome Atlas resource; cBioPortal for Cancer Genomics revealed that FAM40B was more frequently amplified or mutated than FAM40A (links in Supplementary Fig. 6e ). Many FAM40B mutations cluster around the C-terminal region of the protein that binds to the catalytic sub-units of PP2A (Fig. 7a) and we reasoned that C-terminal-truncation mutants would no longer bind PPP2CA and PPP2CB and would drive cell contraction when overexpressed. Indeed, the truncation mutants FAM40B-642stop and FAM40B-764stop are defective in binding to PP2A catalytic sub-units and drive cell contraction when overexpressed (Fig. 7b,c) .
MST3 and 4 regulate PPP1CB to modulate the cytoskeleton
We next sought to identify MST3 and 4 substrates responsible for control of cell morphology. Although Ezrin is an MST4 substrate 32, 47 , overexpression of an active Ezrin T567D mutant did not phenocopy FAM40A depletion (Fig. 1m) , nor was it able to rescue FAM40B-, MST3 and 4-or CCM3-depleted cell phenotypes ( Supplementary  Fig. 7 ). We thus postulated that some of the 32 genes identified in Supplementary Fig. 1 may be involved in control of the cytoskeleton by MST3 and 4. Depletion of PPP1CB in MDA-MB-231 cells, but not other phosphatase components from the border cell migration screen, led to highly contracted blebbing cells (Fig. 8a-d and Supplementary ±s.e.m. after depletion of PPP1R14C with multiple siRNA oligonucleotides (n = 7 fields of cells). Unpaired Student's t-test (two-tailed), * P < 0.05, * * P < 0.01, * * * P < 0.001. (l) Quantification of pS19-MLC2/Ezrin-GFP colocalization analysis ±s.e.m. (n: cells; Ctr siRNA, 21; PPP1R14C SP siRNA, 23). All statistical tests were performed using one-way ANOVA, Sidak's multiple comparison test, unless stated otherwise, * * P < 0.01, * * * P < 0.001. All experiments were conducted at least 3 independent times. Scale bars, 10 µm. Fig. 8a and Table 1 ). The effects of MST3 and 4 depletion could be reverted by depletion of PPP1CB (Fig. 8d) , suggesting that MST3 and 4 may regulate the cytoskeleton through modulation of PPP1CB function. PPP1CB could be regulated by phosphorylation in a similar manner to PPP1CA and PPP1CC; however, recombinant MST3 and 4 were unable to phosphorylate the potential regulatory sites of PPP1CB (Ser 311 and Thr 316; Fig. 8e) .
A small-scale screen of peptides from PP1 regulators or cytoskeletal molecules was performed to identify MST3 and 4 substrates (Supplementary Table 2 ). The most highly phosphorylated peptides were from the PPP1R14 family of proteins (Fig. 8e) , which are negative regulators of PPP1CB. PPP1R14A can be positively regulated by phosphorylation 48 and PPP1R14C and PPP1R14D were phosphorylated by MST3 and 4 to similar levels as positive control peptides from Ezrin and PTPN12 (Fig. 8e) . We confirmed that MST3 and 4 phosphorylate PPP1R14C on Ser 73 by kinase assays using wild-type and T73A full-length recombinant protein (Fig. 8f) . PPP1R14C expression in MDA-MB-231 cells was sufficient to drive membrane blebbing (Fig. 8g) , whereas mutation of the MST3 and 4 phosphorylation site to alanine (T73A) prevented regulation of membrane blebbing by PPP1R14C (Fig. 8h) . Expression of the wild-type and T73A mutant demonstrated that a phosho-PPP1R14A antibody cross-reacted with PPP1R14C ( Supplementary Fig. 8b ) and could be used to monitor phosphorylation changes in PPP1R14 proteins. Activation of MST3 and 4 by serum stimulation for one minute led to increased pPPP1R14 staining at cell-cell contacts and around the edge of cell clusters ( Fig. 8i and Supplementary Fig. 8c ). This corresponds to the localization of MST3 following serum stimulation (Fig. 5) , and was reduced by MST3 and 4 depletion (Fig. 8i) . PPP1R14C depletion reduced the cortical localization of pS19-MLC and increased cell area in both A431 and MDA-MB-231 cells (Fig. 8j,k and Supplementary Fig. 8d,e) . PPP1R14C-depleted cells also had broad pERM-positive lamellipodia (Fig. 8j) and reduced co-localization of pS19-MLC and Ezrin (Fig. 8l) . These data establish PPP1R14C as an MST3 and 4 substrate that links phenotypes observed following manipulation of the STRIPAK/PP2A complex to PP1-mediated regulation of the cytoskeleton.
DISCUSSION
Cancer cells can adopt different motility modes [9] [10] [11] : some use lamellipodia and an elongated morphology (mesenchymal), whereas others use either small F-actin-rich protrusions or blebs to extend the plasma membrane forward (amoeboid). Cell motility mode can affect the ability of cancer cells to metastasize 7, 8, 12, 49, 50 and we demonstrate that the STRIPAK complex regulates both how cancer cells move and their ability to metastasize through the function of MST3 and 4. FAM40A and STRN1,3 and 4 antagonize the activity of MST3 and 4 by enabling the catalytic sub-units of the PP2A complex to de-phosphorylate the activation loop of MST3 and 4 ( Supplementary Fig. 8f ). FAM40B2 cannot perform this function and acts as a competitive inhibitor of FAM40A. The effect of FAM40B depletion probably depends on the relative levels of FAM40B1 and FAM40B2. If significant levels of FAM40B2 are present, removing this from the system will favour negative regulation of MST3 and 4 by FAM40A. This could explain the divergent phenotypes reported when FAM40A and FAM40B are depleted 22 . CCM3 localizes MST3 to the edge of cell clusters and cell-cell contacts. Active MST3 and 4 at the cell cortex can phosphorylate PPP1R14C and promote its ability to locally inhibit dephosphorylation of MLC by PPP1CB. This elevates phosphorylated MLC in the cortical actin underlying the plasma membrane. This model is supported by the reduced rate of MLC dephosphorylation in cells with elevated MST3 and 4 activities (Fig. 2e) .
MST3 and 4 can also regulate ERM proteins at the cell cortex, probably through direct phosphorylation 32 . However, MST3 and 4 cannot be the only ERM kinases because the total levels of pERM do not change following MST3 and 4 depletion. Instead pERM is lost from the cell cortex but is prominent in the lamellipodia. SLK or PKC family members may be relevant ERM kinases in this context. Links between CCM3 and ERM proteins have been previously reported in endothelial cells 51, 52 . Although we do not find evidence of STRIPAK components acting upstream of RhoA in cancer cells of epithelial origin (Fig. 2) , we cannot completely exclude negative regulation of Rho signalling by the STRIPAK complex.
We propose that MST3 and 4 coordinate inhibition of MLC dephosphorylation and phosphorylation of ERM proteins at the cell cortex. Absence of MST3 and 4 prevents the co-localization of pS19-MLC with ERM proteins. The spatial segregation of actomyosin machinery from ERM proteins prevents the contractile cytoskeleton from pulling on the plasma membrane efficiently. This facilitates cell spreading, reduces hydrostatic pressure, and leads to contractile force being coupled to integrins through focal adhesions, instead of being exerted on the plasma membrane. The slightly increased focal adhesion numbers that we observe on MST3 and 4 and CCM3 depletion (Fig. 3d) 
may reflect effects through ICAP1 (ref. 53).
We observe significant correlations between activation of MST3 and 4 function and more aggressive breast cancer sub-types and poor prognosis. Cancer genome sequencing has identified frequent mutations in FAM40B, and on the basis of mutation frequency and types, FAM40B was classified as an oncogene 54 . We demonstrate that FAM40B truncation mutants confer a dominant ability for FAM40B to promote a contractile cell phenotype. We propose that FAM40B mutants and high MST3 and 4 activity promote malignancy by coupling contractile cytoskeleton to the plasma membrane and generating significant intra-cellular hydrostatic pressure, which enables migration through confined spaces 55, 56 .
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
Cell culture and transfections. Human A431 and MDA-MB-231 cells were grown in DMEM supplemented with 10% FCS. All cell lines were frequently tested for mycoplasma and were negative. A431 cells were transfected using Dharmafect 2 (Dharmacon). MDA-MB-231 cells were transfected using Lipofectamine 2000 (Invitrogen). In brief, cells were plates at 60% confluence and subjected to transfection the following day using 25-50 nM siRNA. After 24 h of transfection the cells were re-plated onto plastic or a gel consisting of 4.25-4.75 mg ml −1 collagen I (BD Biosciences; catalogue no. 354249) and 2-2.5 mg ml −1 Matrigel (BD Biosciences; catalogue no. 354234). Cells were either fixed or lysed 48-72 h posttransfection. The phenotypic changes observed in the screen were blindly scored by a minimum of 3 people. The screen was performed three times in A431 cells. siRNA oligonucleotides were purchased from Dharmacon and Qiagen. A comprehensive list of all siRNA oligonucleotides used in this study can be found in Supplementary  Table 3 . Ectopic expression of fluorescently tagged proteins was generated by classical DNA transfection. In most cases cells were treated with antibiotics to generate stable pools of cells. Once stable, the cells were FACS sorted for further purification. All cloning was conducted using classical techniques and the Gibson Assembly cloning kit (NEB catalogue no. E5510S). A comprehensive list of all expression vectors used in this study can be found in Supplementary Table 3 . The pEzrin-GFP and pEzrin-T567D-GFP vectors were gifts from R. Lamb, Cancer Research Centre, University of Liverpool, UK. The pEGFP-MLC, pROCK:ER and pROCK KD:ER vectors were gifts from M. F. Olson, Beatson Institute for Cancer Research, Glasgow, UK. The pEGFP-MST4 vector was a gift from F. Barr, University of Oxford, UK. The pEGFP-CCM3 vector was a gift from J. Zalvide, University of Santiago de Compostela, Spain. The Raichu-RhoA biosensor (1523x) was a gift from M. Matsuda, Kyoto University, Japan.
Western blotting, RNA extraction and quantitative real-time PCR. Western blotting was performed using standard techniques. A comprehensive list of all antibodies used in this study can be found in Supplementary Table 3 . Total RNA was prepared using RNeasy (Qiagen), according to the manufacturer's instructions. cDNA was generated from 2 µg total RNA using M-MLV H-point mutant reverse transcriptase (Promega) and random hexamer primers. qPCR was carried out on cDNA using EXPRESS SYBR GreenER SuperMix with Premixed ROX or Platinum SYBR Green qPCR SuperMix-UDG with ROX (Invitrogen), according to the manufacturer's instructions. The housekeeping gene coding for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a control. A comprehensive list of all qPCR primers used in this study can be found in Supplementary Table 3 .
Immunoprecipitation assays. Myc-tagged FAM40A, FAM40B1 or FAM40B2 was transiently transfected into 293T cells plated on 10 cm plates together with tGFP-MST3, Flag-PPP2CA, Flag-PPP2CB or Flag-PPP2R1A. After 12 h of transfection the cells were lysed in TNN-HS buffer 25 followed by centrifugation for 10 min at 16,000g at 4 • C. Lysates were incubated with 5 µg of anti-Myc antibody (9E10 clone) for 4 h tumbling at 4 • C in the presence of 50 µl of 50% slurry TNN-HS pre-washed protein-G Dyna beads (Invitrogen). Beads were collected by magnetic force and washed 4 times with 1 ml TNN-HS buffer. The immune-precipitates were analysed by SDS-PAGE and protein detection with anti-Flag-HRP-conjugated (Cell Signaling), anti-Myc (cl. 9E10) or Turbo-GFP (Evrogen) antibodies.
Recombinant protein and soluble peptide kinase assay. Assays were carried out in a final volume of 30 µl buffer containing 160 µM peptide or 400 ng recombinant protein substrate in 50 mM Hepes pH 7.5, 10 mM MgCl 2 , 1 mM EGTA, 0.01% Brij35. The phosphorylation reactions were initiated by the addition of 100 ng of kinase (MST3/4, Abcam) and ATP (10 µM cold plus 0.3 µl [ 32 P]ATP 370 MBq per 60 µl). All phosphorylation reactions were carried out at 30 • C for 30 min. Analysis of recombinant protein substrate was performed by SDS-PAGE; 25 µl of the reaction loaded, the gel was fixed, stained and dried using standard methods. Analysis of peptide substrates was performed by transferring 25 µl to 2 cm square pieces of phosphor-cellulose p81 paper (Whatman). The papers were immediately immersed in 1%v/v phosphoric acid, washed 3 times for 5 min, washed once in acetone, dried and the radioactivity was measured by Cherenkov counting.
Fly strains and immunofluorescence of the egg chambers. UAS.IR transgenic
RNAi lines (on the second or third chromosome) were obtained from the Vienna Drosophila RNAi Centre 57 and driven in the border cells by the Gr1-Gal4 driver. Two independent RNAi lines for each gene were used to confirm the migration delay phenotype: Fam40/CG11526-106184 and 16211 (data not shown); Cka/CG7392-106971 and 35232 (data not shown). Twelve thousand siRNA lines crossed onto the hh.GAL4 driver were assumed to have no strong phenotype within the egg chamber (either border cell or follicular epithelium) if the flies were healthy and viable-these were not further analysed. The 1,393 lethal siRNA lines were further analysed for egg chamber phenotypes by crossing the Gr1.GAL4 driver; 594 of these lines were fertile and therefore not analysed further. The remaining 844 lines were analysed in more detail by crossing onto the actin>stop>Gal4 driver. Ovary dissection was performed in phosphate-buffered saline (PBS), followed by fixation in 4% paraformaldehyde (PFA) in PBS for 20 min. After fixation, ovaries were rinsed with PBS-T (1× PBS and 0.1% Triton X-100) and then incubated in blocking solution (1× PBS, 0.1% Triton X-100 and 5% goat serum) for at least 30 min. Ovaries were then incubated with the primary antibodies diluted in PBS-T and 5% goat serum overnight at 4 • C, washed with PBS-T, followed by secondary antibody staining. For phospho-MyoII staining, ovaries were fixed in 8% PFA for 10 min, blocked for 1 h in PBS-T with 5% BSA, and then incubated with the primary antibody at 4 • C overnight in PBS-T, 5% BSA. The following primary antibodies were used: rabbit anti-phospho-MLC2 (1:50; Cell Signaling), mouse antiDlg (4F3, 1:250; DSHB), rabbit anti-phospho-ERM (1:100; Cell Signaling). Goat secondary antibodies conjugated to Alexa Fluor 546 or 647 (Invitrogen) were used at a dilution of 1:500 in PBS-T and incubated for 2 h at room temperature. Ovaries were further stained with DAPI (Invitrogen) in PBS-T to visualize nuclei before mounting in Vectashield (Vector Labs). Images were acquired on a Leica SP5 confocal microscope using ×40 oil-immersion objectives, and were processed with Adobe Photoshop CS3.
Confocal microscopy. All fluorescent images were acquired using either Zeiss LSM510, LSM710 or LSM780 inverted confocal microscopes. For time-lapse analysis the cells were kept at 37 • C and 5 or 10% CO 2 . For immunofluorescence analysis the cells were fixed with 4% PFA in PBS and permeabilized using 0.2% Triton X-100 in PBS before blocking with 3% BSA in PBS. Cells were stained with primary antibodies overnight at 4 • C followed by DAPI, Phalloidin-TRITC (Sigma #P1951) and fluorescently conjugated secondary antibodies for 2-6 h at room temperature. When staining pERM proteins, the 4% PFA fixation was replaced by a 30 min, 10% TCA fixation on ice. A comprehensive list of all antibodies used in this study can be found in Supplementary Table 3 . Cell phenotypes were determined manually by placing cells into categories depending on the organization of the actin cytoskeleton. FRET imaging was performed using a Zeiss LSM780 system using constructs and methods described previously 58 . Briefly, cells were excited using 458 nm light and the ratio of YFP to CFP fluorescence was determined. The quantification represents a ratiometric measurement, not FRET efficiency. Controls involving imaging after photo-bleaching of the acceptor and imaging CFP alone were performed to confirm that FRET was being measured (data not shown).
Structured illumination microscopy. Cells were seeded in 35 mm glass
Mattek dishes and processed for immunostaining as described above. After staining they were then mounted in a 1:1 mixture of glycerol and MOWIOL. Imaging was performed using a Zeiss ELYRA PS1 system (Zeiss) using a PlanApochromat ×63/1.40 Oil DIC M27 objective. Data were processed using the structured illumination microscopy tools in the Zen 2011 software (Zeiss). Channel alignment was performed with 0.1 µm TetraSpeck fluorescent microspheres (Life Technologies).
Image analysis metrics. The cell area (±s.e.m.) of MDA-MB-231 cells was determined using Volocity software. Images were thresholded on the basis of Factin staining and cells automatically identified. A431 grow in clumps and were not amenable to this method. The average cell area of A431 cells was quantified by dividing the total area of cells in a field of view (as determined using Factin thresholding) by the number of nuclei in that field of view. The mean fluorescent intensity (±s.e.m.) of either pS19-MLC or pERM was determined using Volocity software. Images were thresholded on the basis of F-actin staining, cells automatically identified, and the mean intensity of staining in other fluorescent channels was extracted. Multiple fields of views were quantified for each independent experiment. The co-localization of Ezrin-GFP and pS19-MLC staining was determined following siRNA transfection of MDA-MB-231 or A431 cells stably expressing Ezrin-GFP. Confocal images were thresholded on the GFP channel to exclude any cells that were not expressing Ezrin-GFP; the correlation coefficient (r) of pixel intensity values for Ezrin-GFP and pS19-MLC fluorescence was extracted from ZEN software.
Matrix displacement analysis.
For matrix displacement measurements, preparation of polyacrylamide gels of defined elastic moduli was performed as previously described 59 . Briefly, 3 kPa polyacrylamide gels were embedded with 0.2 µm fluorescent beads and coated with 0.1 mg ml −1 collagen I. Following siRNA transfection, MDA-MB-231 cells were then seeded on top of the 3 kPa matrices. One day after seeding the fluorescent beads underlying the cells were imaged before and after the addition of tryspin/EDTA and cytochalasinD/blebbistatin to disrupt all cell-matrix adhesions and actomyosin force generation. These images then enabled the matrix displacement to be tracked between the substrate with cells exerting force on it (before) and the relaxed state (after).
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Quantification of GFP-tagged protein translocation. Fluorescently tagged A431 cells were plated on glass Mattek dishes and left overnight. The next day the medium was changed to serum-free medium and left overnight. FBS to a final concentration of 10% was added to the cells and image acquisition was initiated immediately. Image acquisition was performed at 37 • C and 10% CO 2 on a Leica LSM780 inverted confocal microscope using a ×63 1.54 NA objective (Leica). Cells were imaged every 20 s for 12 min. Quantification of GFP-tagged protein at cell-cell junctions and cell borders was accomplished by measuring the mean fluorescence intensity within a 15 × 15 pixel area from each frame using ImageJ. The mean fluorescence intensity within that square was divided by the mean fluorescence intensity of a second square having a 15 × 15 pixel area placed adjacently to the first square, but within the cytosol of the cell. All values were then normalized to t = 0.
Phase-contrast time-lapse and migration analysis. Bright-field and epifluorescence time-lapse imaging of MDA-MB-231-H2b-mCherry cells was performed at 37 • C and 5% CO 2 with an inverted microscope (Nikon ECLIPSE TE2000-E). Bright-field and epifluorescence images were taken every 5 min for 12 h through a ×10 PlanFluor, NA 0.3 Ph1, Nikon objective. The imaging system includes a Xenon PE300BF lamp, an Andor iXonEM+ DU-888 back-illuminated EMCCD scientific camera, and System Control Software MetaMorph Version 7.7.3.0 (Molecular Devices). Cell tracking was performed by tracking the H2b-mCherry-positive nuclei using MetaMorph software. Cell speed and persistence were quantified using Mathematica Software.
Transwell migration assays. MDA-MB-231 cells were transfected with siRNA as described above. The day after transfection the cells were trypsinized and seeded into Transwell inserts with 8 µm pores (Costar no. 3422) in serum-free media while the lower reservoir contained 10% FBS. After 48 h the cells were fixed and images were acquired of the cells that remained in the inserts and those that had migrated through the pores. The number of cells in each image was quantified using ImageJ, and the migrated cells/total cell number was calculated.
Morphometric analysis of focal adhesion. siRNA-transfected MDA-MB-231 cells were plated on glass, and fixed 72 h post-transfection with 4% PFA. Focal adhesions were stained using phospho-tyrosine antibody (clone 4G10). Image acquisition was performed on a Leica LSM510 inverted confocal microscope using a ×63 1.2W C-Apochromat water objective (Leica). Images were taken with a pin hole of 0.6 to minimize the z-section. Pixel dimension was 0.07 µm × 0.07 µm. The morphometric analysis was conducted using ImageJ. Focal adhesions of individual cells were identified by edge finding and then converted into a binary image. Particle analysis was then applied to determine morphometric values including numbers, area, perimeter and shape factor. Focal adhesion greater than 0.5 µm 2 was included in the final analysis.
Flow cytometry. Cell surface expression of β1-integrins was analysed by flow cytometry 72 h post-transfection. Cell surface levels of active b1-integrin were determined using the HUTS-21 antibody (1:100), which specifically binds the active form of β 1 -integrins. Total levels of β 1 -integrins were determined by co-incubating the HUTS-21 antibody with 0.5 mM MnCl 2 , a stimuli that forces integrins into an active conformation. Cells were stained with secondary Alexa488-labelled antibody (1:500) and analysed by flow cytometry (FACSCalibur; BD Biosciences). All steps were performed on ice to limit the analysis to cell surface expression. The ratio of active versus total β 1 -integrin levels was calculated.
Experimental metastasis assays. Fluorescently tagged MDA-MB-231 cells were injected into the tail vein of ∼6-week-old female nude mice. No statistical method was used to predetermine the sample size. No method of randomization was used and no blind experiments were conducted. All animal experiments were conducted in accordance with the Home Office Animals (Scientific Procedures) Act of 1986. Two days before injection either the mCherry-or GFP-positive cells were transfected with siRNA targeting the gene of interest, and the other coloured cells were transfected with a control siRNA. Mice were always injected in a 1:1 mixture of GFPand mCherry-expressing MDA-MB-231 (1 million cells were injected). Additional controls for the ratio of mCherry and GFP cells were conducted by seeding 10 µl of the 1:1 cell suspension into a glass-bottom dish coated with poly-lysine (Sigma); after 2 h, cells were fixed in 4% PFA and imaged with a Zeiss LSM 780 confocal microscope using a Plan-Neofluar 10 × 0.3 objective. The mice were euthanized after either 2 or 48 h, and evaluated for fluorescent tumour cells in the lungs using confocal imaging and the same settings and laser power as used for the control plates. The ratio between red and green fluorescent cell area of each lung set as well as the control plate were then determined by automated quantification using Volocity software. The metastatic index was then calculated taking into the account the initial ratio at the time of injection (control plates on poly-lysine or lungs after 2 h) and the ratio observed within the lungs at 48 h.
Quantification of spontaneous metastasis. Fluorescently tagged MDA-MB-231 cells were injected into the fat pad of ∼6-week-old female nude mice. No method of randomization was used and no blind experiments were conducted. All animal experiments were conducted in accordance with the Home Office Animals (Scientific Procedures) Act of 1986. Mice were always injected in a 1:1 mixture of GFP-and mCherry-expressing MDA-MB-231. When tumours were 7-10 mm in diameter the mice were euthanized and imaged using intravital imaging. Spontaneous metastases were quantified by determining the ratio of GFP-versus mCherry-positive cell area in the inguinal lymph nodes and normalizing it to the ratio within the primary tumour. The ratio between red and green fluorescent cell area was determined by automated quantification using Volocity software.
Analysis of clinical data sets. Kaplan Meier plots for distant metastasis-free survival (Gene set for Breast cancer) were generated using the online resource http://kmplot.com/analysis/ with auto cutoff selected 60 . Expression data for different breast cancer sub-types (gene set analysis tumours) were obtained using the Lund University online resource http://co.bmc.lu.se/gobo/gsa.pl (ref. 61 ). Frequencies of mutations, deletions, amplifications, and multiple alterations in FAM40A/STRIP1 and FAM40B/STRIP2 in all cancer types were generated using the online resource http://www.cbioportal.org/public-portal/index.do (refs 62,63) .
Statistical analyses.
All statistical tests were performed using one-way ANOVA, Sidak's multiple comparison test or unpaired Student's t-test (two-tailed), * P < 0.05, * * P < 0.01, * * * P < 0.001. No statistical method was used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment apart from the different siRNA screens that were blinded. Ctr, 43; FAM40ARNAi, 23; CKARNAi, 28) . Estimation of the distance travelled by the border cell cluster at stage 10 (lower histogram, n=animals; Ctr, 64; FAM40ARNAi, 47; CKARNAi, 43): 100% -reached the oocyte, >50% -travelled more than half the distance toward the oocyte; >25% -travelled more than one forth the distance toward the oocyte; 0% -did not leave the anterior part of the egg chamber. (f) Representative images of the egg chamber at stage 9 stained for with DAPI (cyan) and pMoesin (red, upper panels) or pMyosin2 (red, lower panels). The insets represent a zoomed area. Scale bars, 10 μm, unless indicated otherwise. STRIPAK complex controls the spatial regulation of actomyosin and ERM activities at cell-cell junction and cell edges. The STRIPAK complex thereby acts in synergy with other regulators of contractions, such as RhoA/ROCK. The STRIPAK complex is composed of PP2A phosphatases that can inactivate the kinases MST3&4 within the complex. PP2A is directed to the activation loop of the kinases by the scaffolding proteins FAM40A and FAM40B1, while FAM40B2 cannot bind PP2A catalytic sub-units and acts as a competitive inhibitor. CCM3 recruits MST3&4 to sites of actomyosin contraction where it phosphorylates and activates members the PP1 phosphatase inhibitor family, PPP1R14A-D, leading to increased contraction. MST3&4 may also directly phosphorylate ERM proteins. Ultimately, the STRIPAK complex determines if the actomyosin network is coupled to the plasma membrane (ERM). Low MST3&4 activities couple the actomyosin network to the ECM and favour 2D migration, while high MST3&4 activities couple the actomyosin network to the plasma membrane facilitating 3D migration through confined environment.
